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Abstract. The clinical picture of patients with sickle cell anemia (SCA) is associated with several 
complications some of which could be fatal. The objective of this study is to analyze the causes of 
death and the effect of sex and age on survival of Brazilian patients with SCA. Data of patients 
with SCA who were seen and followed at HEMORIO for 15 years were retrospectively collected 
and analyzed. Statistical modeling was performed using survival analysis in the presence of 
competing risks estimating the covariate effects on a sub-distribution hazard function. Eight 
models were implemented, one for each cause of death. The cause‐specific cumulative incidence 
function was also estimated. Males were most vulnerable for death from chronic organ damage 
(p = 0.0005) while females were most vulnerable for infection (p=0.03). Age was significantly 
associated (p ≤ 0.05) with death due to acute chest syndrome (ACS), infection, and death during 
crisis. The lower survival was related to death from infection, followed by death due to ACS. The 
independent variables age and sex were significantly associated with ACS, infection, chronic 
organ damage and death during crisis. These data could help Brazilian authorities strengthen 
public policies to protect this vulnerable population. 
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Introduction. The clinical picture of patients with 
sickle cell anemia (SCA) is associated with several 
complications some of which could be fatal.1-3 Besides 
the recurrent episodes of acute vaso-occlusive crises 
(VOCs), these complications include, among other 
things, stroke, acute chest syndrome, splenic and 
hepatic sequestration, infections, priapism, leg ulcers, 
retinopathy, avascular necrosis, cholelithiasis, 
progressive organ failure and death.3 The frequency 
and severity of these complications vary with age, time 
and sex. Ischemic stroke, for example, is more 
common in children whereas leg ulcers are more 
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common in adults.3 The probability of the recurrence of 
each complication at a certain age has not been well 
studied. The objective of this study is to analyze the 
causes of death using the competitive risk statistical 
model.4 This analysis is based on the recently reported 
retrospective data on the pattern of morbidity and 
mortality in children, adolescents and adults in Rio de 
Janeiro, Brazil.5 
 
Material and Methods. 
Patients: Retrospective data were collected and 
analyzed in patients with SCA including patients with 
sickle-β0-thalassemia (Sβ0thal), who were seen and 
followed at HEMORIO for 15 years from January 1, 
1998, through December 31, 2012. Children and adults 
were included in the study. The total number of 
patients enrolled was 1676. The diagnosis of SCA 
including sickle-β0-thalassemia was confirmed by high-
performance liquid chromatography (HPLC). The date 
and cause of death were confirmed from the patients’ 
charts if death occurred at HEMORIO. Death outside 
HEMORIO was suspected if patients failed to show up 
for follow-up and confirmed by interviews with the 
patients’ families and from death certificates. None of 
the patients was taking hydroxyurea. The study was 
approved by the Institutional Review Board (IRB) of 
HEMORIO. 
 
Statistical analysis. Statistical modeling was performed 
using Survival analysis in the presence of competing 
risks. 
Basically, three functions are used in survival data: 
the survival function, the cumulative distribution 
function, and the hazard function. 
In survival analysis, it is common to investigate the 
lifetime related to a single cause of death. However, 
there are more complex models, in which the death of 
the individual is related to one of several possible 
causes identified in the study. These models are called 
competing risk models being suitable in studies where 
individuals are exposed to more than one cause of 
failure or event. 
Gooley et al.6 define the competing risk as a 
survival model in which the occurrence of an event 
prevents or alters the probability of occurrence of 
another event. 
In general, three types of approach are used in the 
presence of competing risks:6 1 - Event-free survival 
model, using the Cox model4 considering the time until 
the occurrence of the first event. This model is not 
suitable because it does not consider the various risk 
factors; 2 – Cause-specific hazard model, where the 
Cox model is used considering one of the events as the 
main cause and the rest are censored. This approach is 
also unsuitable because it is not possible to estimate the 
common effect of a covariate for competing outcomes. 
Additionally, the sum of the cumulative distribution 
function for each outcome is different from the 
cumulative distribution function of the overall curve. It 
would also be necessary to be valid the assumption of 
independence between the event of interest and other 
competing events, considered censorship, which rarely 
occurs; and 3 – Hazard of subdistribution model, using 
the cumulative incidence function. This model does not 
require any assumption of independence of competing 
risks.7 
The cumulative incidence function, or 
subdistribution function, introduced by Kalbleisch & 
Prentice,8 is defined as the joint probability 
𝐹𝑖(𝑡) = 𝑃(𝑇 ≤ 𝑡, 𝐶 = 𝑖),    𝑖 = 1, ⋯ , 𝑝 
That is, 𝐹𝑖(𝑡) is the probability of failure for a 
specific cause, among p possible causes over time. 
Fine and Gray9 proposed a regression model 
implemented on the cumulative incidence function for 
analyzing competing risks. Modeling is performed by 
hazard of subdistribution function, defined as the 
instantaneous hazard of an individual suffering the 
event for a specific cause, conditional to have survived 
until a certain time t. 
γ(𝑡|𝑧) = 𝑒𝑥𝑝(𝛽′𝑧)𝛾0(𝑡) 
Where γ is the hazard of subdistribution; 𝛾0 is the 
baseline hazard of the subdistribution; 𝛽 is a vector of 
coefficients to be estimated; and 𝑧 is the vector of 
independent variables. 
The partial likelihood function is modeled as an 
extension of the Cox proportional hazards model,10 
weighted by 𝑤𝑖𝑗.   
ℒ̃(𝛽) = ∏ (
𝑒𝑥𝑝(𝛽𝑧𝑗)
∑ 𝑤𝑖𝑗𝑒𝑥𝑝(𝛽𝑧𝑖)𝑖∈𝑅𝑗
)
𝑟
𝑗=1
 
In this model, a patient who has suffered a 
competing risk is not removed from the risk set. This 
individual receives a 𝑤𝑖𝑗 =
𝐺(𝑡𝑗)
𝐺(𝑚𝑖𝑛(𝑡𝑖,𝑡𝑗))
 weight, where 
𝐺 is the nonparametric Kaplan-Meier11 distribution of 
the censorship. The weight 𝑤𝑖𝑗 is decreasing due to the 
decay of the Kaplan-Meier curve. The distribution of 
the censorship is given by the pair (𝑇𝑖 , 𝐶𝑖), and 𝑇𝑖 is the 
time measured until the occurrence of the first 
competing event; and 𝐶𝑖 = 0 if it is observed the 
occurrence of some type of event and 𝐶𝑖 = 1 if no 
event occurs.12 Thus, there is an inversion of the usual 
concepts of event and censorship. 
In each instant 𝑡𝑗, in which the event of interest has 
been observed, the risk set is composed of individuals 
who have not suffered any event until the time 𝑡𝑗, 
receiving the weight 𝑤𝑖𝑗 = 1; and those who have 
suffered a competing event before this time 𝑡𝑗 being 
weighted as 𝑤𝑖𝑗 ≤ 1. Thus, given the occurrence of the 
event of interest in time 𝑡𝑗, for each individual who has 
suffered a competing event in 𝑡𝑗, the greater the 
distance between points 𝑡𝑖 and 𝑡𝑗, the lower the weight
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Table 1. Risk of subdistribution regression model. 
  Coefficient Relative Risk Lower 95% CI Upper 95% CI p 
Acute Chest Syndrome  Female -0.3033 0.7384 0.4623 1.1793 0.2042 
(n.º  of events: 71) Age -0.0385 0.9623 0.9418 0.9832 0.0004 
Infection Female 0.5000 1.6487 1.0496 2.5897 0.0300 
(n.º  of events: 82) Age -0.0194 0.9807 0.9621 0.9997 0.0467 
Stroke Female -0.4294 0.6509 0.3260 1.2995 0.2235 
(n.º  of events: 33) Age -0.0154 0.9847 0.9558 1.0145 0.3102 
Cardiac Causes Female 0.6576 1.9301 0.5933 6.2791 0.2746 
(n.º  of events: 13) Age 0.0176 1.0177 0.9724 1.0652 0.4500 
Chronic Organ Damage Female -1.5853 0.2049 0.0837 0.5016 0.0005 
(n.º  of events: 30) Age 0.0282 1.0286 0.9991 1.0589 0.0575 
 
𝑤𝑖𝑗.
12 
 
Results. The causes of death of the 281 patients who 
died were analyzed. The most common causes of death 
included infection mostly due to sepsis, acute chest 
syndrome (ACS), overt stroke, sudden during crisis and 
organ damage due to hepatic or renal failure. Thirteen 
patients died of unrelated causes mostly due to trauma. 
In this work, survival analysis was performed using 
the risk of sub-distribution regression model.9 These 
models consider the cumulative incidence function, 
using a weighting factor for each individual 
considering all outcomes. Thus, the individual who 
suffers from the competing event is not censored 
receiving a weight that decreases gradually with time.  
Eight models were implemented, one for each cause 
of death related to SCDA, as shown in Table 1: Acute 
Chest Syndrome, Infection, Stroke, Cardiac Causes, 
Chronic Organ Damage, Death During Crisis, Other 
(Splenic Sequestration, Hemolytic Crisis or Hepatic 
Crisis) and Unknown. 
It is observed that the males are most vulnerable for 
death from chronic organ damage (p = 0.0005) while 
females are most vulnerable for death from infection 
(p=0.03). Sex did not show a statistically significant 
association with other causes of death. Age is 
significantly (p ≤ 0.05) associated with death due to 
ACS, infection, and death during crisis. The increase of 
one year in age corresponds to a 3.8% reduction in the 
risk of death by ACS; 1.9% in the risk of death from 
infection; and 6.2% for death during crisis. On the 
other hand, the increase of one year in age implies an 
increase of 2.8% in the risk of death from chronic 
organ damage, at a significance level of 10%. 
Figure 1 shows the cumulative incidence function, 
where one can observe that the lower survival is related 
to death from infection, followed by death due to ACS. 
Compared to the model of competing risks, the 
independent variables age and sex were significantly 
associated with the outcomes with an asterisk.  
 
Figure 1. 
 
Analyses were performed with the use of packages 
“cmprsk” 13 and “mstate” 14-16 of R software.17 
 
Discussion. Despite all Brazilian efforts, the mortality 
of patients with SCA is still very high in Brazil.2,3 
These efforts included, among other things, newborn 
screening, penicillin/antibiotic prophylaxis, vaccination 
including anti-pneumococcus, anti-meningococcus, 
annual anti-influenza, blood transfusion and 
transcranial doppler determinations.3,5,18  In this study, 
we used the competitive risk analysis to evaluate the 
causes of mortality among our cohort. 
A competing risk is an event whose occurrence 
either precludes the occurrence of another event under 
examination or fundamentally alters the probability of 
occurrence of this other event, so it is an ideal model to 
analyze causes of death in a specific disease with 
multiple possible causes of death as in SCD.6 It was 
used before in other chronic disease but never is SCD 
in Brazil before.19 
The competitive risk model was used because it is 
adequate in survival analysis when there are mutually 
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exclusive events, that is when the occurrence of one 
event prevents another event occurring. In the article, 
events are deaths from various causes. The cumulative 
incidence function (represented by the graph) evaluates 
for each patient the probability of occurrence of a 
specific event before a certain time t. The risk sub-
distribution model estimates the effect of independent 
variables for each specific event, considering the 
presence of competitive risks. 
The reasons for the relatively low death rate of 
females due to chronic organ damage are unknown. 
Possibilities include gender differences in nitric oxide 
availability,20 and the influence of the X-chromosome 
linked hemoglobin (Hb) F gene21 which may be 
protective against organ damage in females. However, 
Dover’s et al. study was not confirmed by additional 
studies. In addition, the increase in Hb F by the X-
chromosome is minimal in comparison to other studies 
indicating that Hb F has to be as high as ≥ 8% to be 
effective. Other determinants of survival such as 
hyperviscosity, alpha genotypes, and beta haplotypes 
could not be determined at HEMORIO. 
 
Conclusions. Mortality among patients with SCD 
using the competing risks of death was evaluated for 
the first time in a single institution in Rio de Janeiro, 
Brazil.  
In this article, we used the subdistribution hazard 
function which evaluates the effect of covariates on the 
cumulative incidence function for each of the 
competitive events. This modeling is advantageous 
because it makes no assumption about the 
independence of competitive events. 
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